triazoles has been researched along with panobinostat in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 8 (80.00) | 24.3611 |
| 2020's | 2 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, S; Evans, D; Kijima, I; Ye, J | 1 |
| Chen, S; Chu, P; Kanaya, N; Kubo, M; Liu, Z; Nishimura, R; Okido, M; Osako, T; Petrossian, K; Shimada, K; Takahashi, M; Warden, C; Ye, J; Yuan, YC | 1 |
| Bullen, CK; Durand, CM; Laird, GM; Siliciano, JD; Siliciano, RF | 1 |
| Cheng, WJ; Churchill, MJ; Ellett, AM; Gorry, PR; Gray, LR; Jacobson, JC; Lewin, SR; Lu, HK; Moso, MA; On, H; Papaioannou, C; Purcell, DF; Raison, JA; Roberts, E; Wesselingh, SL | 1 |
| Atmadibrata, B; Bradner, JE; Liu, PY; Liu, T; Lock, RB; Marshall, GM; Shahbazi, J | 1 |
| Allred, JB; Goetz, MP; Ingle, JN; Moreno-Aspitia, A; Northfelt, DW; Perez, EA; Tan, WW | 1 |
| Hulleman, E; Li, M; Liu, F; Ma, J; Meng, W; Monje, M; Nagaraja, S; Ponnuswami, A; Sun, W; Swigut, T; Tang, Y; Taylor, KR; Vitanza, NA; Woo, PJ; Wysocka, J; Zhang, L | 1 |
| Boeva, V; De Preter, K; De Vloed, F; De Wyn, J; Decaesteker, B; Deforce, D; Denecker, G; Depuydt, P; Dolman, EM; Dreidax, D; Durinck, K; Essing, AHW; Gartlgruber, M; Henssen, A; Herrmann, C; Kholosy, WM; Koopmans, B; Loontiens, S; Mestdagh, P; Molenaar, JJ; Nunes, C; Rombaut, D; Schleiermacher, G; Schulte, JH; Speleman, F; Van Loocke, W; van Nes, J; Van Neste, C; Van Nieuwerburgh, F; Vanhauwaert, S; Verboom, K; Versteeg, R; Westermann, F | 1 |
| Bantscheff, M; Becher, I; Bergamini, G; Childs, DD; Eberl, HC; Faelth-Savitski, M; Franken, H; Heller, B; Huber, W; Kalxdorf, M; Krause, J; Kurzawa, N; Perrin, J; Poeckel, D; Rau, CE; Rutkowska, A; Savitski, MM; Sevin, DC; Stonehouse, E; Strohmer, K; Thomson, DW; Vappiani, J; Werner, T | 1 |
| Alexander, G; Challagundla, KB; Chaturvedi, NK; Coulter, DW; Joshi, SS; Kesherwani, V; Kling, MJ; McIntyre, EM; Mishra, NK; Ray, S | 1 |
1 trial(s) available for triazoles and panobinostat
| Article | Year |
|---|---|
Phase I Study of Panobinostat (LBH589) and Letrozole in Postmenopausal Metastatic Breast Cancer Patients.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers, Tumor; Breast Neoplasms; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Hydroxamic Acids; Immunoenzyme Techniques; Indoles; Letrozole; Lymphatic Metastasis; Maximum Tolerated Dose; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Nitriles; Panobinostat; Postmenopause; Prognosis; Receptor, ErbB-2; Receptors, Estrogen; Receptors, Progesterone; Survival Rate; Triazoles | 2016 |
9 other study(ies) available for triazoles and panobinostat
| Article | Year |
|---|---|
The HDAC inhibitor LBH589 (panobinostat) is an inhibitory modulator of aromatase gene expression.
Topics: Aromatase; Aromatase Inhibitors; Base Sequence; Breast Neoplasms; CCAAT-Enhancer-Binding Protein-delta; Cell Line, Tumor; Cell Proliferation; Coculture Techniques; DNA Primers; Down-Regulation; Drug Synergism; Epigenesis, Genetic; Female; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Indoles; Letrozole; Neoplasms, Hormone-Dependent; Nitriles; Panobinostat; Promoter Regions, Genetic; Triazoles | 2010 |
Inhibition of the proliferation of acquired aromatase inhibitor-resistant breast cancer cells by histone deacetylase inhibitor LBH589 (panobinostat).
Topics: Aged; Androstadienes; Animals; Antineoplastic Agents; Apoptosis; Aromatase Inhibitors; Breast Neoplasms; Cell Cycle Checkpoints; Cell Proliferation; Disease-Free Survival; Drug Resistance, Neoplasm; Female; Gene Expression; Gene Knockdown Techniques; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Indoles; Letrozole; MCF-7 Cells; Mice; Mice, Inbred BALB C; Mice, Nude; Middle Aged; NF-kappa B p50 Subunit; Nitriles; Panobinostat; Triazoles; Tumor Burden; Xenograft Model Antitumor Assays | 2013 |
New ex vivo approaches distinguish effective and ineffective single agents for reversing HIV-1 latency in vivo.
Topics: Anti-HIV Agents; Azepines; Bryostatins; CD4-Positive T-Lymphocytes; Cell Cycle Proteins; Depsipeptides; Disulfiram; Histone Deacetylase Inhibitors; HIV Infections; HIV-1; Humans; Hydroxamic Acids; Indoles; Ionomycin; Lymphocyte Activation; Nuclear Proteins; Panobinostat; Tetradecanoylphorbol Acetate; Transcription Factors; Triazoles; Virus Latency; Vorinostat | 2014 |
Toxicity and in vitro activity of HIV-1 latency-reversing agents in primary CNS cells.
Topics: Acetamides; Astrocytes; Azepines; Cell Line; Cell Survival; Depsipeptides; Disulfiram; Fetus; Histone Deacetylase Inhibitors; HIV-1; Humans; Hydroxamic Acids; Indoles; Macrophages; Neurons; Panobinostat; Piperazines; Primary Cell Culture; Transcription, Genetic; Triazoles; Virus Activation; Virus Latency; Virus Replication; Vorinostat | 2016 |
The Bromodomain Inhibitor JQ1 and the Histone Deacetylase Inhibitor Panobinostat Synergistically Reduce N-Myc Expression and Induce Anticancer Effects.
Topics: Animals; Antineoplastic Agents; Apoptosis; Azepines; Cell Line, Tumor; Cell Proliferation; Female; Histone Deacetylase Inhibitors; Humans; Hydroxamic Acids; Indoles; Mice; Mice, Inbred BALB C; Neuroblastoma; Nuclear Proteins; Oncogene Proteins; Panobinostat; Promoter Regions, Genetic; Proteins; Proto-Oncogene Proteins c-myc; Transcription, Genetic; Triazoles; Xenograft Model Antitumor Assays | 2016 |
Transcriptional Dependencies in Diffuse Intrinsic Pontine Glioma.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Azepines; Brain Stem Neoplasms; Cell Cycle Proteins; Cell Proliferation; Chromatin Assembly and Disassembly; Cyclin-Dependent Kinase-Activating Kinase; Cyclin-Dependent Kinases; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Drug Synergism; Female; Gene Expression Regulation, Neoplastic; Glioma; Histone Deacetylase Inhibitors; Histones; Humans; Hydroxamic Acids; Indoles; Male; Mice, Inbred NOD; Mice, SCID; Mutation; Nuclear Proteins; Panobinostat; Phenylenediamines; Primary Cell Culture; Protein Kinase Inhibitors; Pyrimidines; Receptors, Eph Family; RNA Interference; Signal Transduction; Time Factors; Transcription Factors; Transcription, Genetic; Transfection; Triazoles; Tumor Cells, Cultured; Xenograft Model Antitumor Assays | 2017 |
TBX2 is a neuroblastoma core regulatory circuitry component enhancing MYCN/FOXM1 reactivation of DREAM targets.
Topics: Antineoplastic Agents; Azepines; Brain Neoplasms; Cell Line, Tumor; Cell Survival; Cyclin-Dependent Kinase-Activating Kinase; Cyclin-Dependent Kinases; DNA Copy Number Variations; Epigenesis, Genetic; Forkhead Box Protein M1; Gene Expression Regulation, Neoplastic; HEK293 Cells; Histones; Humans; Kv Channel-Interacting Proteins; N-Myc Proto-Oncogene Protein; Neuroblastoma; Organoids; Panobinostat; Phenylenediamines; Pyrimidines; Repressor Proteins; Signal Transduction; T-Box Domain Proteins; Triazoles; Tumor Suppressor Protein p53 | 2018 |
Identifying drug targets in tissues and whole blood with thermal-shift profiling.
Topics: Animals; Azepines; Blood; Hep G2 Cells; Humans; Kidney; Liver; Lung; Male; Mass Spectrometry; Mice; Organ Specificity; Panobinostat; Protein Stability; Proteome; Rats; Small Molecule Libraries; Spleen; Testis; Thermodynamics; Triazoles; Vemurafenib | 2020 |
A novel dual epigenetic approach targeting BET proteins and HDACs in Group 3 (MYC-driven) Medulloblastoma.
Topics: Animals; Apoptosis; Azepines; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Cerebellar Neoplasms; Epigenesis, Genetic; Histone Deacetylases; Humans; Medulloblastoma; Mice; Nuclear Proteins; Panobinostat; Proto-Oncogene Proteins c-myc; Transcription Factors; Triazoles | 2022 |